2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$25.49-$0.88 (-3.34%)
Price as of Jul 31, 2026 7:37 PM EDT- $13.2BMarket Cap
- 91.23%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$25.49-$0.88 (-3.34%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.37 | ||
Change | -$0.09 (-0.34%) | ||
Open | $26.46 | ||
High | $26.46 | ||
Low | $25.77 | ||
Previous Close | $26.46 | ||
Volume | 5,193,856 | ||
30-Day Average Volume | 4,618,801 | ||
1-Week Change | 5.86% | ||
1-Month Change | 7.15% | ||
1-Year Change | 91.23% | ||
3-Year Change | 118.48% | ||
5-Year Change | -27.69% | ||
Fundamentals | |||
Shares Outstanding | 499.4M | ||
Total Assets | $13.2B | ||
Market Cap | $13.2B | ||
Enterprise Value | $16.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.4B | ||
Net Income | $57.0M | ||
Free Cash Flow | -$38.0M | ||
EBIT | $87.0M | ||
EBITDA | $259.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 2 | ||
P/E | 240 | ||
PEG | 2 | ||
Price/Free Cash Flow | -347 | ||
Price/Operating Cash Flow | 1,013 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue